FDA OKs Liptruzet for High LDL
(MedPage Today) -- The FDA approved Liptruzet, a combination of ezetimibe and atorvastatin, for the treatment of hyperlipidemia, drug maker Merck announced today.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Heart | Lipitor | Merck | Statin Therapy | Vytorin | Zetia | Zivast